Back to top
more

Invesco Biotechnology & Genome ETF: (PBE)

(Delayed Data from NYSE) As of Feb 27, 2026 02:45 PM ET

$81.95 USD

81.945
2,353

+0.61 (0.74%)

Volume: 2,353

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $81.95 +0.01 (0.01 %) 7:54 PM ET

Zacks News

Zacks Equity Research

Is PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) a Hot ETF Right Now?

Smart Beta ETF report for PBE

    Zacks Equity Research

    Trump's Immigration Plans an Overhang on Biotech ETFs?

    Immigration related uncertainty has put biotech ETFs in focus.